Safety considerations in the treatment with anti-CGRP(R) monoclonal antibodies in patients with migraine
- DOI
- 10.3389/fneur.2024.1387044
- Published
- 2024-04-29
- Container
- Frontiers in Neurology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fneur.2024.1387044,
title = {Safety considerations in the treatment with anti-CGRP(R) monoclonal antibodies in patients with migraine},
author = {Britt W. H. Van Der Arend and Nancy Van Veelen and Joëlle E. T. De Ruijter and Michael H. Olsen and Antoinette MaassenVanDenBrink and Gisela M. Terwindt},
year = {2024},
journal = {Frontiers in Neurology},
doi = {10.3389/fneur.2024.1387044},
url = {https://doi.org/10.3389/fneur.2024.1387044}
}RIS
TY - JOUR TI - Safety considerations in the treatment with anti-CGRP(R) monoclonal antibodies in patients with migraine AU - Britt W. H. Van Der Arend AU - Nancy Van Veelen AU - Joëlle E. T. De Ruijter AU - Michael H. Olsen AU - Antoinette MaassenVanDenBrink AU - Gisela M. Terwindt PY - 2024 JO - Frontiers in Neurology DO - 10.3389/fneur.2024.1387044 UR - https://doi.org/10.3389/fneur.2024.1387044 ER -
APA
Arend, B. W. H. V. D., Veelen, N. V., Ruijter, J. E. T. D., Olsen, M. H., MaassenVanDenBrink, A., & Terwindt, G. M. (2024). Safety considerations in the treatment with anti-CGRP(R) monoclonal antibodies in patients with migraine. Frontiers in Neurology. https://doi.org/10.3389/fneur.2024.1387044
Source records
- crossref · retrieved 2026-09-25T20:58:50.666Z